67 related articles for article (PubMed ID: 2154678)
1. Cytostatic effects of 2',3'-dideoxyribonucleosides on transformed human hemopoietic cell lines.
Blakley RL; Harwood FC; Huff KD
Mol Pharmacol; 1990 Feb; 37(2):328-32. PubMed ID: 2154678
[TBL] [Abstract][Full Text] [Related]
2. 2',3'-Dideoxycytidine toxicity in cultured human CEM T lymphoblasts: effects of combination with 3'-azido-3'-deoxythymidine and thymidine.
Törnevik Y; Eriksson S
Mol Pharmacol; 1990 Aug; 38(2):237-43. PubMed ID: 2166904
[TBL] [Abstract][Full Text] [Related]
3. 2',3'-Dideoxycytidine: regulation of its metabolism and anti-retroviral potency by natural pyrimidine nucleosides and by inhibitors of pyrimidine nucleotide synthesis.
Balzarini J; Cooney DA; Dalal M; Kang GJ; Cupp JE; DeClercq E; Broder S; Johns DG
Mol Pharmacol; 1987 Dec; 32(6):798-806. PubMed ID: 2826994
[TBL] [Abstract][Full Text] [Related]
4. Factors determining the activity of 2',3'-dideoxynucleosides in suppressing human immunodeficiency virus in vitro.
Hao Z; Cooney DA; Hartman NR; Perno CF; Fridland A; DeVico AL; Sarngadharan MG; Broder S; Johns DG
Mol Pharmacol; 1988 Oct; 34(4):431-5. PubMed ID: 2459590
[TBL] [Abstract][Full Text] [Related]
5. Effects of 2',3'-dideoxynucleosides on mammalian cells and viruses.
Waqar MA; Evans MJ; Manly KF; Hughes RG; Huberman JA
J Cell Physiol; 1984 Nov; 121(2):402-8. PubMed ID: 6092393
[TBL] [Abstract][Full Text] [Related]
6. Biochemical pharmacology of 2-chlorodeoxyadenosine in malignant human hematopoietic cell lines and therapeutic effects of 2-bromodeoxyadenosine in drug combinations in mice.
Avery TL; Rehg JE; Lumm WC; Harwood FC; Santana VM; Blakley RL
Cancer Res; 1989 Sep; 49(18):4972-8. PubMed ID: 2569929
[TBL] [Abstract][Full Text] [Related]
7. Metabolic pathways for the activation of the antiviral agent 2',3'-dideoxyguanosine in human lymphoid cells.
Bondoc LL; Ahluwalia G; Cooney DA; Hartman NR; Johns DG; Fridland A
Mol Pharmacol; 1992 Sep; 42(3):525-30. PubMed ID: 1328848
[TBL] [Abstract][Full Text] [Related]
8. Determinants of deoxyadenosine toxicity in hybrids between human T- and B- lymphoblasts as a model for the development of drug resistance in T-cell acute lymphoblastic leukemia.
Kurtzberg J; Hershfield MS
Cancer Res; 1985 Apr; 45(4):1579-86. PubMed ID: 3872167
[TBL] [Abstract][Full Text] [Related]
9. Cytotoxic and biochemical effects of thymidine and 3-deazauridine on human tumor cells.
Lockshin A; Mendoza JT; Giovanella BC; Stehlin JS
Cancer Res; 1984 Jun; 44(6):2534-9. PubMed ID: 6722792
[TBL] [Abstract][Full Text] [Related]
10. Metabolism, mitochondrial uptake and toxicity of 2', 3'-dideoxycytidine.
Rossi L; Serafini S; Schiavano GF; Casabianca A; Vallanti G; Chiarantini L; Magnani M
Biochem J; 1999 Dec; 344 Pt 3(Pt 3):915-20. PubMed ID: 10585881
[TBL] [Abstract][Full Text] [Related]
11. Metabolic basis of arabinonucleoside selectivity for human leukemic T- and B-lymphoblasts.
Verhoef V; Fridland A
Cancer Res; 1985 Aug; 45(8):3646-50. PubMed ID: 2410098
[TBL] [Abstract][Full Text] [Related]
12. Dideoxycytidine, an anti-HIV drug, selectively inhibits growth but not phosphatidylcholine metabolism in neuroblastoma and glioma cells.
Cook HW; Spence MW
Neurochem Res; 1989 Mar; 14(3):279-84. PubMed ID: 2542824
[TBL] [Abstract][Full Text] [Related]
13. Resistance to 2-chloro-2'-deoxyadenosine of the human B-cell leukemia cell line EHEB.
Cardoen S; Van Den Neste E; Smal C; Rosier JF; Delacauw A; Ferrant A; Van den Berghe G; Bontemps F
Clin Cancer Res; 2001 Nov; 7(11):3559-66. PubMed ID: 11705877
[TBL] [Abstract][Full Text] [Related]
14. Development of zidovudine (AZT) resistance in Jurkat T cells is associated with decreased expression of the thymidine kinase (TK) gene and hypermethylation of the 5' end of human TK gene.
Wu S; Liu X; Solorzano MM; Kwock R; Avramis VI
J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Jan; 8(1):1-9. PubMed ID: 8548339
[TBL] [Abstract][Full Text] [Related]
15. The in vitro and in vivo anti-retrovirus activity, and intracellular metabolism of 3'-azido-2',3'-dideoxythymidine and 2',3'-dideoxycytidine are highly dependent on the cell species.
Balzarini J; Pauwels R; Baba M; Herdewijn P; de Clercq E; Broder S; Johns DG
Biochem Pharmacol; 1988 Mar; 37(5):897-903. PubMed ID: 2830886
[TBL] [Abstract][Full Text] [Related]
16. Genomic imbalances in T-cell acute lymphoblastic leukemia cell lines.
Gebhart E; Thoma K; Verdorfer I; Drexler HG; Efferth T
Int J Oncol; 2002 Oct; 21(4):887-94. PubMed ID: 12239631
[TBL] [Abstract][Full Text] [Related]
17. Cellular metabolism of 2',3'-dideoxycytidine, a compound active against human immunodeficiency virus in vitro.
Starnes MC; Cheng YC
J Biol Chem; 1987 Jan; 262(3):988-91. PubMed ID: 2433280
[TBL] [Abstract][Full Text] [Related]
18. Sensitivity of human, murine, and rat cells to 5-fluorouracil and 5'-deoxy-5-fluorouridine in relation to drug-metabolizing enzymes.
Peters GJ; Laurensse E; Leyva A; Lankelma J; Pinedo HM
Cancer Res; 1986 Jan; 46(1):20-8. PubMed ID: 2415245
[TBL] [Abstract][Full Text] [Related]
19. Characterization of 2',3'-dideoxycytidine diphosphocholine and 2',3'-dideoxycytidine diphosphoethanolamine. Prominent phosphodiester metabolites of the anti-HIV nucleoside 2',3'-dideoxycytidine.
Hao Z; Stowe EE; Ahluwalia G; Baker DC; Hebbler AK; Chisena C; Musser SM; Kelley JA; Perno CF; Johns DG
Drug Metab Dispos; 1993; 21(4):738-44. PubMed ID: 7690699
[TBL] [Abstract][Full Text] [Related]
20. Growth inhibition of human tumor cells in soft-agar cultures by treatment with low levels of adenosine 5'-triphosphate.
Rapaport E; Fishman RF; Gercel C
Cancer Res; 1983 Sep; 43(9):4402-6. PubMed ID: 6871873
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
